Article Details
Retrieved on: 2025-02-03 19:30:14
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses advancements in treating Leber Congenital Amaurosis, highlighting gene therapies like Luxturna, which targets RPE65 mutations. It relates to the key concept of epidemiology by exploring genetic causes and treatments for this eye disease, utilizing tags like gene therapy, CRISPR editing, and CEP290.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here